• Fri, March 3, 2023
Gary Nachman Maintained (AMRX) at Hold with Decreased Target to $4 on, Mar 3rd, 2023
Gary Nachman of BMO Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $5 to $4 on, Mar 3rd, 2023.
Gary, nor any peers, have made any analyst calls on AMRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30